NGLFINE
NSENGL Fine-Chem Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹3,193.60
17.70 (0.55%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.97K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
41.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,175.5+171.7%
52W High₹3,329-4.1%
Current Price
₹3,193.60
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹2,554.88
Upper Circuit₹3,832.32
Reference Price
₹3,193.60
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹3376.8
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹3376.8
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
84%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
3053.29
EMA50
2813.42
EMA200
2131.94
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹3200.00
₹3232.00
Support (Below)
₹3005.00
₹2900.00
₹2767.90
₹2566.67
₹2497.00
Volume Analysis
TrendDECREASING
Change-62.40%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹3161.66
3% Risk₹3097.79
5% Risk₹3033.92
7% Risk (Custom)
₹2970.05Technical Levels
1x ATR (Volatility)₹3001.75
2x ATR (Swing)₹2809.90
3x ATR (Trend)₹2618.05
Immediate Support₹3005.00
Moving Averages
EMA 9 (Short-term)₹3147.57
EMA 20 (Medium-term)₹3053.29
EMA 50 (Trend)₹2813.42
EMA 200 (Long-term)₹2131.94
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹89.7 Cr | ₹104.2 Cr | ₹120.3 Cr | ₹127.5 Cr |
| Net Profit | ₹82,40,000 | ₹9.2 Cr | ₹9.6 Cr | ₹15.7 Cr |
| EPS | — | ₹14.96 | ₹15.58 | ₹25.40 |
| Operating Profit | ₹5.6 Cr | ₹17.3 Cr | ₹19.2 Cr | ₹26.9 Cr |
ROE
7.48%
ROCE
8.36%
Debt/Equity
0.27
Current Ratio
1.98
OPM
21.12%
NPM
12.31%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| NGL Fine-Chem Limited | ₹3,193.60 | -0.55% | 41.3 | ₹1.97K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 12 Aug 2025 | Dividend - Rs 1.75 Per Share | DIVIDEND |
| 16 Aug 2024 | Annual General Meeting/Dividend - Rs 1.75 Per Share | AGM |
| 18 Aug 2023 | Annual General Meeting/Dividend - Rs 1.75 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NGLFINE
View All
positive
ET Markets - Stocks 8d ago
Sumitomo Chemical shares soar 11%, record biggest single-day surge in nearly 2 years. Here’s why
Sumitomo Chemical India shares surged around 11% as heavy volumes and a major development at its Japanese parent’s Korean subsidiary lifted sentiment. Dongwoo Fine-Chem’s joint venture with Samsung Electro-Mechanics for glass core substrates boosted optimism around next-generation semiconductor packaging demand. The stock hit a fresh high amid strong trading activity.
CHEMICALNGLFINEPARAGONSUMICHEMChemicalsFinancial Services
NEWS
positive
Business Standard - Markets 50d ago
NGL Fine Chem consolidated net profit rises 2398.15% in the March 2026 quarter
Sales rise 57.13% to Rs 149.23 crore
NGLFINEHealthcare
NEWS
negative
Business Standard - Markets 64d ago
Rossell Techsys Ltd leads losers in 'B' group
NGL Fine Chem Ltd, Globus Spirits Ltd, Team India Guaranty Ltd and STL Networks Ltd are among the other losers in the BSE's 'B' group today, 08 May 2026.
BSEGLOBUSSPRNGLFINEROSSELLINDROSSTECHSGLSTLNETWORKTEAMGTYCapital GoodsFast Moving Consumer Goods